Quantum Biopharma Statistics
Quantum Biopharma (0K91) Stock Statistics & Valuation Metrics
Total Valuation
Quantum Biopharma has a market cap or net worth of EUR 15.17M. The enterprise value is EUR 13.44M.
- Market Cap
- EUR 15.17M
- Enterprise Value
- EUR 13.44M
Share Statistics
Quantum Biopharma has 8,087,479 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,087,479
- Owned by Insiders
- 10.68%
- Owned by Institutions
- 10.31%
Financial Efficiency
Quantum Biopharma’s return on equity (ROE) is -3.79 and return on invested capital (ROIC) is -219.67%.
- Return on Equity (ROE)
- -3.79
- Return on Assets (ROA)
- -2.35
- Return on Invested Capital (ROIC)
- -219.67%
- Return on Capital Employed (ROCE)
- -3.00
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.54M
- Employee Count
- 17
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Quantum Biopharma is -0.36. Quantum Biopharma’s PEG ratio is -0.00.
- PE Ratio
- -0.36
- PS Ratio
- 0.00
- PB Ratio
- 1.69
- Price to FCF
- -2.40
- Price to Operating Cash Flow
- -2.48
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Quantum Biopharma had revenue of 0 and earned -26.18M in profits. Earnings per share was -8.11.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -15.30M
- Pretax Income
- -26.96M
- Net Income
- -26.18M
- EBITDA
- -25.79M
- Earnings Per Share (EPS)
- -8.11
Cash Flow
In the last 12 months, operating cash flow was -5.42M and capital expenditures -6, giving a free cash flow of -5.42M billion.
- Operating Cash Flow
- -5.42M
- Free Cash Flow
- -5.42M
- Free Cash Flow per Share
- -0.81
Dividends & Yields
Quantum Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -38.11%
- Earnings Yield
- -169.28%
Stock Price Statistics
- Beta
- 0.54
- 52-Week Price Change
- -75.10%
- 50-Day Moving Average
- 2.56
- 200-Day Moving Average
- 3.12
- Relative Strength Index (RSI)
- 34.93
- Average Volume (3m)
- 1,368
Important Dates
Quantum Biopharma upcoming earnings date is Mar 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 26, 2027
- Ex-Dividend Date
- ―
Financial Position
Quantum Biopharma as a current ratio of 1.07, with Debt / Equity ratio of 27.10%
- Current Ratio
- 1.07
- Quick Ratio
- 1.06
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- -24.74
Taxes
In the past 12 months, Quantum Biopharma has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Quantum Biopharma EV to EBITDA ratio is -0.49, with an EV/FCF ratio of -2.13.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.49
- EV to Free Cash Flow
- -2.13
- EV to Operating Cash Flow
- -2.13
Balance Sheet
Quantum Biopharma has EUR 9.73M in cash and marketable securities with EUR 962.16K in debt, giving a net cash position of EUR 8.77M billion.
- Cash & Marketable Securities
- EUR 9.73M
- Total Debt
- EUR 962.16K
- Net Cash
- EUR 8.77M
- Net Cash Per Share
- EUR 1.08
- Tangible Book Value Per Share
- EUR 0.27
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Quantum Biopharma is EUR 7.17, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 7.17
- Price Target Upside
- 317.57% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 59.35%
